Occudo Quantitative Strategies LP Aytu Biopharma, Inc Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.08 - $1.55 $66,145 - $94,931	-61,246 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.35 - $2.95 $16,217 - $35,438	-12,013 Reduced 16.4%	61,246 $83,000
Q3 2021 Nov 15, 2021	BUY	$2.78 - $5.12 $34,280 - $63,134	12,331 Added 20.24%	73,259 $211,000
Q2 2021 Aug 16, 2021	BUY	$4.73 - $7.56 $3,859 - $6,168	816 Added 1.36%	60,928 $305,000
Q1 2021 May 14, 2021	BUY	$6.23 - $9.88 $374,497 - $593,906	60,112 New	60,112 $457,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.